Insiders at Dendreon Corporation Cash In on Drug Approval

WSJ -- Dendreon Corp. President and Chief Executive Mitchell Gold sold more than $28 million of company stock in the hours after the U.S. Food and Drug Administration approved the cancer treatment Provenge late last week.